2,600 Shares in Xylem Inc (XYL) Purchased by New England Research & Management Inc.

New England Research & Management Inc. bought a new position in shares of Xylem Inc (NYSE:XYL) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,600 shares of the industrial products company’s stock, valued at approximately $206,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Thrivent Financial for Lutherans grew its holdings in shares of Xylem by 1.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 7,864 shares of the industrial products company’s stock valued at $525,000 after buying an additional 138 shares during the period. Cascade Investment Advisors Inc. boosted its stake in Xylem by 25.0% in the 4th quarter. Cascade Investment Advisors Inc. now owns 1,000 shares of the industrial products company’s stock worth $67,000 after purchasing an additional 200 shares during the period. Independent Investors Inc. boosted its stake in Xylem by 2.5% in the 4th quarter. Independent Investors Inc. now owns 9,500 shares of the industrial products company’s stock worth $633,000 after purchasing an additional 230 shares during the period. Mercer Capital Advisers Inc. boosted its stake in Xylem by 33.3% in the 4th quarter. Mercer Capital Advisers Inc. now owns 1,000 shares of the industrial products company’s stock worth $67,000 after purchasing an additional 250 shares during the period. Finally, Macquarie Group Ltd. boosted its stake in Xylem by 9.1% in the 4th quarter. Macquarie Group Ltd. now owns 3,104 shares of the industrial products company’s stock worth $207,000 after purchasing an additional 260 shares during the period. 86.90% of the stock is owned by hedge funds and other institutional investors.

In related news, insider Colin R. Sabol sold 15,930 shares of the company’s stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $80.45, for a total value of $1,281,568.50. Following the transaction, the insider now owns 54,543 shares in the company, valued at approximately $4,387,984.35. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Kenneth Napolitano sold 35,526 shares of the company’s stock in a transaction dated Monday, February 4th. The shares were sold at an average price of $70.17, for a total transaction of $2,492,859.42. The disclosure for this sale can be found here. In the last quarter, insiders sold 80,195 shares of company stock worth $6,000,933. 0.85% of the stock is owned by company insiders.

XYL has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Xylem from a “hold” rating to a “sell” rating in a research note on Sunday, January 6th. Oppenheimer set a $80.00 target price on shares of Xylem and gave the stock a “buy” rating in a research note on Monday, February 4th. ValuEngine lowered shares of Xylem from a “buy” rating to a “hold” rating in a research note on Monday, February 4th. BMO Capital Markets reaffirmed a “buy” rating and issued a $85.00 target price on shares of Xylem in a research note on Monday, February 25th. Finally, Boenning Scattergood reaffirmed a “buy” rating on shares of Xylem in a research note on Friday, March 22nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and ten have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $79.64.

Shares of XYL stock traded up $0.93 on Friday, reaching $83.11. The stock had a trading volume of 621,345 shares, compared to its average volume of 859,363. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.08 and a current ratio of 1.51. The stock has a market cap of $14.69 billion, a price-to-earnings ratio of 28.86, a PEG ratio of 1.43 and a beta of 1.14. Xylem Inc has a 12 month low of $60.65 and a 12 month high of $83.76.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, January 31st. The industrial products company reported $0.88 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.88. Xylem had a net margin of 10.54% and a return on equity of 19.89%. The business had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.36 billion. Sell-side analysts predict that Xylem Inc will post 3.31 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/04/26/new-england-research-management-inc-buys-new-position-in-xylem-inc-xyl.html.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Further Reading: Real Estate Investment Trust (REIT) ETF

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.